Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Alviggi, C, Esteves, SC, Orvieto, R, Conforti, A, La Marca, A, Fischer, R, Andersen, CY, Bühler, K, Sunkara, SK, Polyzos, NP, Strina, I, Carbone, L, Bento, FC, Galliano, D, Yarali, H, Vuong, LN, Grynberg, M, Drakopoulos, P, Xavier, P, Llacer, J, Neuspiller, F, Horton, M, Roque, M, Papanikolaou, E, Banker, M, Dahan, MH, Foong, S, Tournaye, H, Blockeel, C, Vaiarelli, A, Humaidan, P, Ubaldi, FM & POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group 2020, 'COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management', Reproductive Biology and Endocrinology, vol. 18, no. 1, pp. 45. https://doi.org/10.1186/s12958-020-00605-z

APA

Alviggi, C., Esteves, S. C., Orvieto, R., Conforti, A., La Marca, A., Fischer, R., Andersen, C. Y., Bühler, K., Sunkara, S. K., Polyzos, N. P., Strina, I., Carbone, L., Bento, F. C., Galliano, D., Yarali, H., Vuong, L. N., Grynberg, M., Drakopoulos, P., Xavier, P., ... POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group (2020). COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reproductive Biology and Endocrinology, 18(1), 45. https://doi.org/10.1186/s12958-020-00605-z

CBE

Alviggi C, Esteves SC, Orvieto R, Conforti A, La Marca A, Fischer R, Andersen CY, Bühler K, Sunkara SK, Polyzos NP, Strina I, Carbone L, Bento FC, Galliano D, Yarali H, Vuong LN, Grynberg M, Drakopoulos P, Xavier P, Llacer J, Neuspiller F, Horton M, Roque M, Papanikolaou E, Banker M, Dahan MH, Foong S, Tournaye H, Blockeel C, Vaiarelli A, Humaidan P, Ubaldi FM, POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group. 2020. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reproductive Biology and Endocrinology. 18(1):45. https://doi.org/10.1186/s12958-020-00605-z

MLA

Vancouver

Author

Alviggi, Carlo ; Esteves, Sandro C ; Orvieto, Raoul ; Conforti, Alessandro ; La Marca, Antonio ; Fischer, Robert ; Andersen, Claus Y ; Bühler, Klaus ; Sunkara, Sesh K ; Polyzos, Nikolaos P ; Strina, Ida ; Carbone, Luigi ; Bento, Fabiola C ; Galliano, Daniela ; Yarali, Hakan ; Vuong, Lan N ; Grynberg, Michael ; Drakopoulos, Panagiotis ; Xavier, Pedro ; Llacer, Joaquin ; Neuspiller, Fernando ; Horton, Marcos ; Roque, Matheus ; Papanikolaou, Evangelos ; Banker, Manish ; Dahan, Michael H ; Foong, Shu ; Tournaye, Herman ; Blockeel, Christophe ; Vaiarelli, Alberto ; Humaidan, Peter ; Ubaldi, Filippo M ; POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group. / COVID-19 and assisted reproductive technology services : repercussions for patients and proposal for individualized clinical management. In: Reproductive Biology and Endocrinology. 2020 ; Vol. 18, No. 1. pp. 45.

Bibtex

@article{a0380c8d10a34c68983d2ebcb4b5df88,
title = "COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management",
abstract = "The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.",
keywords = "Betacoronavirus, Coronavirus, Coronavirus Infections, Female, Fertilization in Vitro, Humans, Infertility, Female/therapy, Pandemics, Pneumonia, Viral, Pregnancy, Reproductive Health Services/organization & administration, Reproductive Techniques, Assisted, Sperm Injections, Intracytoplasmic, In vitro fertilization, Intracytoplasmic sperm injection, Assisted reproductive technology, COVID-19, Poseidon criteria, Infertility, Viewpoint",
author = "Carlo Alviggi and Esteves, {Sandro C} and Raoul Orvieto and Alessandro Conforti and {La Marca}, Antonio and Robert Fischer and Andersen, {Claus Y} and Klaus B{\"u}hler and Sunkara, {Sesh K} and Polyzos, {Nikolaos P} and Ida Strina and Luigi Carbone and Bento, {Fabiola C} and Daniela Galliano and Hakan Yarali and Vuong, {Lan N} and Michael Grynberg and Panagiotis Drakopoulos and Pedro Xavier and Joaquin Llacer and Fernando Neuspiller and Marcos Horton and Matheus Roque and Evangelos Papanikolaou and Manish Banker and Dahan, {Michael H} and Shu Foong and Herman Tournaye and Christophe Blockeel and Alberto Vaiarelli and Peter Humaidan and Ubaldi, {Filippo M} and {POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group}",
note = "Publisher Copyright: {\textcopyright} 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = may,
day = "13",
doi = "10.1186/s12958-020-00605-z",
language = "English",
volume = "18",
pages = "45",
journal = "Reproductive Biology and Endocrinology",
issn = "1477-7827",
publisher = "BioMed Central Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - COVID-19 and assisted reproductive technology services

T2 - repercussions for patients and proposal for individualized clinical management

AU - Alviggi, Carlo

AU - Esteves, Sandro C

AU - Orvieto, Raoul

AU - Conforti, Alessandro

AU - La Marca, Antonio

AU - Fischer, Robert

AU - Andersen, Claus Y

AU - Bühler, Klaus

AU - Sunkara, Sesh K

AU - Polyzos, Nikolaos P

AU - Strina, Ida

AU - Carbone, Luigi

AU - Bento, Fabiola C

AU - Galliano, Daniela

AU - Yarali, Hakan

AU - Vuong, Lan N

AU - Grynberg, Michael

AU - Drakopoulos, Panagiotis

AU - Xavier, Pedro

AU - Llacer, Joaquin

AU - Neuspiller, Fernando

AU - Horton, Marcos

AU - Roque, Matheus

AU - Papanikolaou, Evangelos

AU - Banker, Manish

AU - Dahan, Michael H

AU - Foong, Shu

AU - Tournaye, Herman

AU - Blockeel, Christophe

AU - Vaiarelli, Alberto

AU - Humaidan, Peter

AU - Ubaldi, Filippo M

AU - POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group

N1 - Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/5/13

Y1 - 2020/5/13

N2 - The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.

AB - The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.

KW - Betacoronavirus

KW - Coronavirus

KW - Coronavirus Infections

KW - Female

KW - Fertilization in Vitro

KW - Humans

KW - Infertility, Female/therapy

KW - Pandemics

KW - Pneumonia, Viral

KW - Pregnancy

KW - Reproductive Health Services/organization & administration

KW - Reproductive Techniques, Assisted

KW - Sperm Injections, Intracytoplasmic

KW - In vitro fertilization

KW - Intracytoplasmic sperm injection

KW - Assisted reproductive technology

KW - COVID-19

KW - Poseidon criteria

KW - Infertility

KW - Viewpoint

U2 - 10.1186/s12958-020-00605-z

DO - 10.1186/s12958-020-00605-z

M3 - Review

C2 - 32404170

VL - 18

SP - 45

JO - Reproductive Biology and Endocrinology

JF - Reproductive Biology and Endocrinology

SN - 1477-7827

IS - 1

ER -

ID: 61254126